Patients with alcoholism, anxiety and the AG genotype may have increased concentrations of alprazolam as compared to patients with the GG genotype. This annotation over covers the pharmacokinetic relationship between rs35599367 and alprazolam and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect concentrations of alprazolam in a patient.